Total Liabilities: The total value of all possible claims against the corporation.
Madrigal Pharmaceuticals, Inc. (MDGL) had Total Liabilities of $235.21M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-373.63M |
|
-- |
|
-- |
|
$380.50M |
|
$-380.50M |
|
$6.87M |
|
$-373.63M |
|
$-373.63M |
|
$-373.63M |
|
$-373.63M |
|
$-373.63M |
|
$-373.63M |
|
$-380.50M |
|
$-377.56M |
|
18.69M |
|
18.69M |
|
$-19.99 |
|
$-19.99 |
|
Balance Sheet Financials | |
$637.28M |
|
$1.55M |
|
$3.27M |
|
$640.55M |
|
$118.55M |
|
$115.48M |
|
$116.67M |
|
Total Liabilities |
$235.21M |
$405.33M |
|
$405.33M |
|
$405.33M |
|
19.88M |
|
Cash Flow Statement Financials | |
$-324.23M |
|
$-502.52M |
|
$595.12M |
|
$331.55M |
|
$99.92M |
|
$-231.63M |
|
$49.73M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
5.38 |
|
-- |
|
-- |
|
0.22 |
|
0.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-325.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-92.18% |
|
-92.18% |
|
-58.33% |
|
-71.74% |
|
$20.39 |
|
$-17.43 |
|
$-17.35 |